Cargando…

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.

Prognostic factors have been studied in 59 men with clinical Stage I non-seminomatous germ-cell tumours of the testis (NSGCTT) seen at the Royal Marsden Hospital between 1973 and 1978. Fourteen of the patients relapsed, and 45 have remained continuously disease-free. Two factors were identified whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghavan, D., Peckham, M. J., Heyderman, E., Tobias, J. S., Austin, D. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1982
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010890/
https://www.ncbi.nlm.nih.gov/pubmed/6174137
_version_ 1782136416756563968
author Raghavan, D.
Peckham, M. J.
Heyderman, E.
Tobias, J. S.
Austin, D. E.
author_facet Raghavan, D.
Peckham, M. J.
Heyderman, E.
Tobias, J. S.
Austin, D. E.
author_sort Raghavan, D.
collection PubMed
description Prognostic factors have been studied in 59 men with clinical Stage I non-seminomatous germ-cell tumours of the testis (NSGCTT) seen at the Royal Marsden Hospital between 1973 and 1978. Fourteen of the patients relapsed, and 45 have remained continuously disease-free. Two factors were identified which showed a significant correlation with relapse following radiotherapy: local extent of the primary tumour, and rate of decline of serum alpha-foetoprotein (AFP) and beta-human chorionic gonadotrophin (hCG) levels following orchidectomy. High serum marker levels at the time of referral after orchidectomy were not prognostically significant per se. The presence of tissue-associated hCG in the primary tumour was not prognostically significant. The results were compared with histology and pathological stage of the primary tumour in patients presenting with lung metastases but no clinical evidence of lymph-node disease. Embryonal carcinoma was more commonly associated with a locally invasive primary tumour and with extralymphatic spread than was teratocarcinoma.
format Text
id pubmed-2010890
institution National Center for Biotechnology Information
language English
publishDate 1982
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20108902009-09-10 Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis. Raghavan, D. Peckham, M. J. Heyderman, E. Tobias, J. S. Austin, D. E. Br J Cancer Research Article Prognostic factors have been studied in 59 men with clinical Stage I non-seminomatous germ-cell tumours of the testis (NSGCTT) seen at the Royal Marsden Hospital between 1973 and 1978. Fourteen of the patients relapsed, and 45 have remained continuously disease-free. Two factors were identified which showed a significant correlation with relapse following radiotherapy: local extent of the primary tumour, and rate of decline of serum alpha-foetoprotein (AFP) and beta-human chorionic gonadotrophin (hCG) levels following orchidectomy. High serum marker levels at the time of referral after orchidectomy were not prognostically significant per se. The presence of tissue-associated hCG in the primary tumour was not prognostically significant. The results were compared with histology and pathological stage of the primary tumour in patients presenting with lung metastases but no clinical evidence of lymph-node disease. Embryonal carcinoma was more commonly associated with a locally invasive primary tumour and with extralymphatic spread than was teratocarcinoma. Nature Publishing Group 1982-02 /pmc/articles/PMC2010890/ /pubmed/6174137 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Raghavan, D.
Peckham, M. J.
Heyderman, E.
Tobias, J. S.
Austin, D. E.
Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
title Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
title_full Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
title_fullStr Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
title_full_unstemmed Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
title_short Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
title_sort prognostic factors in clinical stage i non-seminomatous germ-cell tumours of the testis.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010890/
https://www.ncbi.nlm.nih.gov/pubmed/6174137
work_keys_str_mv AT raghavand prognosticfactorsinclinicalstageinonseminomatousgermcelltumoursofthetestis
AT peckhammj prognosticfactorsinclinicalstageinonseminomatousgermcelltumoursofthetestis
AT heydermane prognosticfactorsinclinicalstageinonseminomatousgermcelltumoursofthetestis
AT tobiasjs prognosticfactorsinclinicalstageinonseminomatousgermcelltumoursofthetestis
AT austinde prognosticfactorsinclinicalstageinonseminomatousgermcelltumoursofthetestis